Need product guidance? Chat with our support team.
nigamlifesciences@gmail.com | +91 63552 52584
Nigfenac-SP Tablets
Nigfenac-SP Tablets contain a combination of Aceclofenac, Paracetamol & Serratiopeptidase in tablet form. This prescription medicine is used under medical supervision for the management of pain and inflammation.
Product Overview
Product Overview
Nigfenac-SP Tablets are a prescription combination containing Aceclofenac, Paracetamol and Serratiopeptidase.
Aceclofenac is an NSAID used for pain and inflammation, while Paracetamol provides analgesic and antipyretic action. Serratiopeptidase is included as an enzyme component commonly used in formulations intended to support the management of inflammatory conditions.
The product is intended for use under the direction of a qualified healthcare professional. The appropriate dose and duration of treatment should be determined by the prescribing physician based on the patient's condition.
Product at a Glance
Product Name: Nigfenac-SP Tablets
Generic Name: Aceclofenac, Paracetamol & Serratiopeptidase Tablets
Dosage Form: Tablets
Route of Administration: Oral
Prescription Status: Prescription Medicine
Pack Size: 10 × 10 Tablets
Marketed/Manufactured for: Nigam Lifesciences
Portfolio Category: Pain & Inflammation Care
Online Status: Professional Product Information & Enquiries Only
Product Identification
Brand Name
Nigfenac-SP
Generic Name
Aceclofenac, Paracetamol & Serratiopeptidase Tablets
Dosage Form
Tablets
Route of Administration
Oral
Product Category
Prescription Medicine
Product Status
Professional product information and enquiry only. Not available for direct online purchase.
Composition
Each tablet contains a combination of:
Aceclofenac
Paracetamol
Serratiopeptidase
Note: The uploaded pack image clearly identifies all three active ingredients, but the individual strengths are not sufficiently legible in the supplied images. Enter the exact quantities from the approved product label/specification rather than assuming them.
Product Information
Nigfenac-SP combines an analgesic/anti-inflammatory medicine with Paracetamol and Serratiopeptidase in a convenient tablet formulation.
The combination is intended for the management of pain and inflammation where prescribed by a healthcare professional.
This information is provided for product identification and professional reference. The medicine should be used only according to the approved prescribing information.
Indications
Nigfenac-SP may be prescribed by a healthcare professional for conditions involving:
Pain
Inflammation
Musculoskeletal pain
Pain associated with inflammatory conditions
Swelling associated with certain inflammatory conditions
The exact indication and duration of treatment should be determined by the prescribing physician.
Directions for Use
Take Nigfenac-SP Tablets exactly as prescribed by your healthcare professional.
Swallow the tablet with water and follow the dosage and duration recommended by your physician.
Do not exceed the prescribed dose.
Do not discontinue prescribed treatment without consulting your healthcare provider.
Important Safety Information
Prescription medicine. Use only under medical supervision.
Take only the dose prescribed by your doctor.
Do not combine with other medicines containing Paracetamol unless specifically advised by a healthcare professional.
Inform your doctor if you have a history of stomach ulcers, gastrointestinal bleeding, liver or kidney problems, heart conditions, or NSAID-related reactions.
Inform your healthcare professional about all medicines and supplements you are currently taking.
Do not use after the expiry date.
Do not use if the blister or outer packaging is damaged or tampered with.
Keep out of reach of children.
Seek medical advice if you experience an unexpected or serious reaction.
Storage Information
Store according to the conditions specified on the approved product packaging.
Keep in a cool and dry place.
Protect from excessive heat, moisture, and direct sunlight.
Keep the tablets in their original packaging until use.
Keep out of reach of children.
Quality & Traceability
For accurate product identification and traceability, retain the original carton and blister strip.
For product-related enquiries, provide:
Product name
Batch number
Manufacturing date
Expiry date
Purchase details
Clear photographs of the carton and blister, where applicable
Professional Enquiries & Availability
Nigfenac-SP Tablets are displayed on the Nigam Lifesciences website for professional product information and enquiry purposes.
Availability may vary depending on region and authorized distribution channels.
Healthcare professionals, hospitals, pharmacies, distributors, stockists, and authorized business partners may contact Nigam Lifesciences for current product and distribution information.
Frequently Asked Questions
What is Nigfenac-SP?
Nigfenac-SP is a prescription tablet containing Aceclofenac, Paracetamol and Serratiopeptidase.
What is Nigfenac-SP used for?
It may be prescribed for the management of pain and inflammation associated with various conditions.
How should Nigfenac-SP be taken?
Take it exactly as prescribed by your physician. Swallow the tablet with water.
Can I take Nigfenac-SP with another Paracetamol medicine?
Do not take additional Paracetamol-containing medicines unless your healthcare professional has advised you to do so.
Is Nigfenac-SP a prescription medicine?
Yes. It should be used under the supervision of a qualified healthcare professional.
Can I purchase Nigfenac-SP directly from this website?
No. This page is intended for professional product information and enquiries only.
Disclaimer
The information provided on this page is intended for product identification and professional reference purposes only.
It does not constitute medical advice and should not be used for self-diagnosis or self-medication.
Always read the current approved product label and prescribing information before use. Where any difference exists between this webpage and the physical product pack, the current approved product label and product documentation shall prevail.










